A simple and feasible determination of the selective estrogen receptor modulator raloxifene in pharmaceutical formulation using pretreated boron-doped diamond electrode ЈЕДНОСТАВНО И ИЗВОДЉИВО ОДРЕЂИВАЊЕ СЕЛЕКТИВНОГ МОДУЛАТОРА ЕСТРОГЕНСКИХ РЕЦЕПТОРА РАЛОКСИФЕНА У ФАРМАЦЕУТСКОЈ ФОРМУЛАЦИЈИ КОРИШЋЕЊЕМ ПРЕТХОДНО ТРЕТИРАНЕ ДИЈАМАНТСКЕ ЕЛЕКТРОДЕ ДОПОВАНЕ БОРОМ


Keskin E., Kiran M., Yardım Y.

Journal of the Serbian Chemical Society, cilt.91, sa.2, ss.145-159, 2026 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 91 Sayı: 2
  • Basım Tarihi: 2026
  • Doi Numarası: 10.2298/jsc250718094k
  • Dergi Adı: Journal of the Serbian Chemical Society
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Central & Eastern European Academic Source (CEEAS), Chemical Abstracts Core, Compendex, Directory of Open Access Journals
  • Sayfa Sayıları: ss.145-159
  • Anahtar Kelimeler: boron-doped diamond electrode, pharmaceutical formulation, raloxifene, sensing, square-wave voltammetry
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

This article reports on the development of an electroanalytical method for the quantitative determination of the selective estrogen receptor modulator raloxifene (RLX) using voltammetry at a pretreated boron-doped diamond (BDD) electrode. RLX exhibited irreversible cyclic voltammetric (CV) behavior in 0.04 mol L-1 Britton–Robinson (BR) supporting electrolyte at pH 2, generating two anodic oxidation peaks at approximately 0.79 V (PA1) and 1.46 V (PA2). Scan rate analysis revealed that both adsorption and diffusion mechanisms govern RLX transport to the electrode surface. Consequently, incorporating a preconcentration (deposition) step was hypothesized to enhance analytical sensitivity. Optimal deposition parameters, along with supporting electrolyte pH and square-wave voltammetry (SWV) modulation settings, were systematically optimized. Quantitative analysis was based on the first anodic peak (PA1) in 0.04 mol L-1 BR buffer at pH 2, exhibiting a linear dynamic range from 0.025 to 5.0 μg mL-1 (from 4.9×10-8 to 9.9×10-6 mol L-1) and a detection limit of 0.0073 μg mL-1 (1.4×10-8 mol L-1). The method’s applicability was validated by successfully quantifying RLX in pharmaceutical formulations.